Concepedia

W. Chrzanowski

WC

Statistics

Publications

7

Citations

602

H-Index

7

Active since

1986

Affiliations

Medical University of Białystok(Current)

GlaxoSmithKline (United Kingdom)

Research Triangle Park Foundation

GlaxoSmithKline (United States)

W. Chrzanowski is an author at Medical University of Białystok specializing in psychiatry, pharmacotherapy, and psychopharmacology.

Publications per year

1986–2009

7

Publications

7

Treatment of Schizophrenia With Long-Acting Injectable Risperidone

W. Wolfgang Fleischhacker, Mariëlle Eerdekens, Keith Karcher et al. · The Journal of Clinical Psychiatry · 2003 · 289 citations

, , +17

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine

W. Chrzanowski, Ronald N. Marcus, A. Torbeyns et al. · Psychopharmacology · 2006 · 146 citations

, , +13

Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR

K. Hewett, W. Chrzanowski, Mark F. Schmitz et al. · Journal of Psychopharmacology · 2008 · 57 citations

, , +15

Double-blind, placebo-controlled evaluation of extended-release bupropion in elderly patients with major depressive disorder

K. Hewett, W. Chrzanowski, Riitta Jokinen et al. · Journal of Psychopharmacology · 2009 · 54 citations

, , +17

Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis

Joseph Lejeune, Ilkka Larmo, W. Chrzanowski et al. · International Clinical Psychopharmacology · 2004 · 25 citations

, , +15

1–5 of 7